177 related articles for article (PubMed ID: 11762338)
1. Neuroendocrine aspects of immunolymphoproliferative diseases.
Ferone D; Hofland LJ; Colao A; Lamberts SW; van Hagen PM
Ann Oncol; 2001; 12 Suppl 2():S125-30. PubMed ID: 11762338
[TBL] [Abstract][Full Text] [Related]
2. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
[TBL] [Abstract][Full Text] [Related]
3. Initial staging of lymphoma with octreotide and other receptor imaging agents.
Ferone D; Semino C; Boschetti M; Cascini GL; Minuto F; Lastoria S
Semin Nucl Med; 2005 Jul; 35(3):176-85. PubMed ID: 16098291
[TBL] [Abstract][Full Text] [Related]
4. [Somatostatin receptors in immune system cells].
Ferone D; Lombardi G; Colao A
Minerva Endocrinol; 2001 Sep; 26(3):165-73. PubMed ID: 11753240
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors in malignant lymphomas: targets for radiotherapy?
Dalm VA; Hofland LJ; Mooy CM; Waaijers MA; van Koetsveld PM; Langerak AW; Staal FT; van der Lely AJ; Lamberts SW; van Hagen MP
J Nucl Med; 2004 Jan; 45(1):8-16. PubMed ID: 14734660
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.
Ferone D; Boschetti M; Resmini E; Giusti M; Albanese V; Goglia U; Albertelli M; Vera L; Bianchi F; Minuto F
Ann N Y Acad Sci; 2006 Jun; 1069():129-44. PubMed ID: 16855140
[TBL] [Abstract][Full Text] [Related]
7. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R
Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
De Jong M; Valkema R; Jamar F; Kvols LK; Kwekkeboom DJ; Breeman WA; Bakker WH; Smith C; Pauwels S; Krenning EP
Semin Nucl Med; 2002 Apr; 32(2):133-40. PubMed ID: 11965608
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.
Reubi JC; Waser B; van Hagen M; Lamberts SW; Krenning EP; Gebbers JO; Laissue JA
Int J Cancer; 1992 Apr; 50(6):895-900. PubMed ID: 1348240
[TBL] [Abstract][Full Text] [Related]
10. Molecular biology of the receptors for somatostatin and cortistatin.
Kreienkamp HJ
Results Probl Cell Differ; 1999; 26():215-37. PubMed ID: 10453466
[No Abstract] [Full Text] [Related]
11. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine tumors in the brain.
Cavalla P; Schiffer D
Ann Oncol; 2001; 12 Suppl 2():S131-4. PubMed ID: 11762340
[TBL] [Abstract][Full Text] [Related]
13. Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours.
Allia E; Tarabra E; Volante M; Cerrato M; Ghigo E; Muccioli G; Papotti M
J Pathol; 2005 Nov; 207(3):336-45. PubMed ID: 16161007
[TBL] [Abstract][Full Text] [Related]
14. Functional role of somatostatin receptors in neuroendocrine and immune cells.
Hofland LJ; van Hagen PM; Lamberts SW
Ann Med; 1999 Oct; 31 Suppl 2():23-7. PubMed ID: 10574151
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptides, via specific receptors, regulate T cell adhesion to fibronectin.
Levite M; Cahalon L; Hershkoviz R; Steinman L; Lider O
J Immunol; 1998 Jan; 160(2):993-1000. PubMed ID: 9551939
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin, cortistatin and their receptors in tumours.
Volante M; Rosas R; Allìa E; Granata R; Baragli A; Muccioli G; Papotti M
Mol Cell Endocrinol; 2008 May; 286(1-2):219-29. PubMed ID: 18248880
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor distribution and function in immune system.
Ferone D; van Hagen PM; Semino C; Dalm VA; Barreca A; Colao A; Lamberts SW; Minuto F; Hofland LJ
Dig Liver Dis; 2004 Feb; 36 Suppl 1():S68-77. PubMed ID: 15077914
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin analogue scintigraphy of malignant lymphomas.
Vanhagen PM; Krenning EP; Reubi JC; Mulder AH; Bakker WH; Oei HY; Löwenberg B; Lamberts SW
Br J Haematol; 1993 Jan; 83(1):75-9. PubMed ID: 8094627
[TBL] [Abstract][Full Text] [Related]
19. Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system.
Dalm VA; van Hagen PM; van Koetsveld PM; Langerak AW; van der Lely AJ; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2003 Jan; 88(1):270-6. PubMed ID: 12519865
[TBL] [Abstract][Full Text] [Related]
20. Receptor scintigraphy of non-neuroendocrine cancers with In-111 pentetreotide.
Limouris GS; Rassidakis A; Kondi-Paphiti A; Triantafyllou N; Manetou A; Gennatas K; Vitoratos N; Gregoriou O; Stavraka A; Vlahos L
Hybridoma; 1997 Feb; 16(1):133-7. PubMed ID: 9085140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
